Australia markets closed

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
27.17-0.58 (-2.09%)
At close: 04:00PM EDT
27.17 0.00 (0.00%)
After hours: 05:27PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close27.75
Open27.80
Bid27.11 x 300
Ask27.19 x 300
Day's range26.97 - 27.97
52-week range16.58 - 45.58
Volume1,397,016
Avg. volume1,166,628
Market cap3.948B
Beta (5Y monthly)0.70
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    Should You Hold Immunovant (IMVT)?

    Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]

  • Zacks

    Here's Why You Should Add Immunovant (IMVT) to Your Portfolio

    Immunovant's (IMVT) late-stage studies evaluating its lead candidate, batoclimab, for various autoimmune indications are progressing well. Several data readouts are expected in 2024 and 2025.

  • Zacks

    What Makes Immunovant (IMVT) a New Buy Stock

    Immunovant (IMVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).